Our multidisciplinary gastroenterology and hepatology providers from Columbia and Weill Cornell Medicine provide comprehensive and compassionate care for young patients presenting with conditions effecting the entire gastrointestinal tract and nutritional concerns. As one of the largest pediatric GI programs in the tri-state area, our clinicians work to expand the understanding of childhood digestive disorders through a robust research program and offer patients access to the latest treatments through clinical trials.
Pediatric Gastroenterology
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
